Results 131 to 140 of about 11,360 (208)

Prevalence of antimalarial drug resistance markers and factors associated with Plasmodium falciparum infection in asymptomatic children prior to rectal artesunate implementation in Kapolowe Health District, Democratic Republic of the Congo. [PDF]

Malar J
Luzolo Khote F, Raposo M, Maseko T, Kanyamukenge D, Hachizovu S, Makenga G, Mukomena E, Kakudji A, Mutombo A, Kikunda G, Sombola J, Maketa V, Nambozi M, Duparc S, Rietveld H, Alifrangis M, Hansson H, Wellmann L, Ouare N, Manyando C, Van Geertruyden JP, Baraka V, Muhindo Mavoko H.   +22 more
europepmc   +1 more source

Malaria Epidemiology and <i>Plasmodium</i> Species-Specific Antimalarial Treatment Patterns Among RDT-Confirmed Cases in Northwestern Pakistan. [PDF]

Trop Med Infect Dis
Mansoor A, Narjis G, Abdelmalek IB, Firasat S, Naz I, Afshan K.   +5 more
europepmc   +1 more source

Efficacy of artemether lumefantrine vs chloroquine for the treatment of Plasmodium Vivax infection in Pakistan. [PDF]

Sci Rep
Khan S, Muqtadir J, Abbas SA, Ayoob K, Wahab A, Zaidi SHM, Das B, Bhatti S, Vohra EA.   +8 more
europepmc   +1 more source

Artemisinin resistance and Nigeria's malaria burden: urgent policy imperatives from the WHO World Malaria Report 2025! [PDF]

Int J Equity Health
Musa SS, Laguitan RVM, Fadele KP, Malinda RP, Sium AF, Lucero-Prisno DE.   +5 more
europepmc   +1 more source

Genomic profiling of drug resistance markers in Plasmodium falciparum samples from the Democratic Republic of the Congo (2017) and Tanzania (2020-2021). [PDF]

J Antimicrob Chemother
Khote FL, Muhindo Mavoko H, Mitashi P, Mandoko P, Mbongi D, Makenga G, Minja DTR, Francis F, Kavishe R, van Geertruyden JP, Kahunu GM, Menard D, Baraka V.   +12 more
europepmc   +1 more source

Therapeutic efficacy of artemether-lumefantrine and molecular markers of antimalarial drug resistance in Benin, 2022. [PDF]

Malar J
Cavros I, Kpemasse A, Maye ASY, Saliou R, Kpanou S, Houndjo W, Aissan J, Affoukou CD, Yamonmi D, Affoukou M, Zlochevska A, Deme AB, Diallo MA, Ngom B, Sene A, Sow D, Condo P, Gnanguenon V, Hassani AS, Hounto AO.   +19 more
europepmc   +1 more source

Efficacy of artemether-lumefantrine for uncomplicated plasmodium falciparum malaria treatment in mozambique: a systematic review and meta-analysis. [PDF]

Malar J
Nhama A, Aide P, Torres-Fernandez D, Varo R, Nhacolo A, Bassat Q.   +5 more
europepmc   +1 more source

Genomic surveillance reveals co-occurrence of Plasmodium falciparum drug resistance variants across diverse transmission settings in Ethiopia. [PDF]

Nat Microbiol
Letebo A, Vanheer LN, Engdaw M, Ejigu LA, Hailu Alemayehu D, Deressa JD, Adnew B, Ayele A, Bezabih MK, Demisse M, Seyoum T, Shiferaw M, Sime H, Weldemariam AG, Shimelash A, Tafa EB, Chali W, Alemayehu L, Kassa FA, Zeleke AJ, Hamza TA, Tamirat AB, Misganaw T, Bogale A, Abriham ZY, Nasir Y, Jebessa G, Yohannes M, Kebede BA, Ayele MK, Abdo M, Habtamu G, Gizat A, Phelan J, Matlock B, Fidock DA, Campino S, Assefa A, Koepfli C, Massebo F, Tadesse FG.   +40 more
europepmc   +1 more source

Treatment Failure and Post-Artesunate Delayed Haemolysis in a Returned Traveller From Uganda With Partially Drug-Resistant Severe Plasmodium falciparum Malaria. [PDF]

Med J Aust
Travis J, McCarthy K, Chapman P, Huang L, Tan A, Cheng Q, Barber BE.   +6 more
europepmc   +1 more source

Targeted Genomic Surveillance Unveils Genetic Variations Linked to Regional Malaria Drug Resistance Dynamics in India. [PDF]

Open Forum Infect Dis
Khilari A, Sharma S, Bajpai M, Viswan K A, Chaturvedi R, Mirdha BR, Rahi M, Sharma A, Shanmugam D.   +8 more
europepmc   +1 more source